AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR

AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR

Submitted by admin on February 28, 2019 - 11:45pm
Source: 
Pharmaceutical Business Review
News Tags: 
AstraZeneca
type 2 diabetes
Farxiga
Xigduo XR
FDA
Headline: 
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
snippet: 

The expanded Farxiga and Xigduo XR labels have been approved to treat patients with T2D and moderate renal impairment.

Do Not Allow Advertisers to Use My Personal information